A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

NCT00057265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: telbivudine or lamivudine

Sponsor

Novartis

Collaborators

[object Object]